IRIS Accounts Production v25.1.4.42 09789457 Board of Directors Board of Directors 1.10.23 30.9.24 30.9.24 false true false false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh097894572023-09-30097894572024-09-30097894572023-10-012024-09-30097894572022-09-30097894572022-10-012023-09-30097894572023-09-3009789457ns15:EnglandWales2023-10-012024-09-3009789457ns14:PoundSterling2023-10-012024-09-3009789457ns10:Director12023-10-012024-09-3009789457ns10:Director22023-10-012024-09-3009789457ns10:PrivateLimitedCompanyLtd2023-10-012024-09-3009789457ns10:SmallEntities2023-10-012024-09-3009789457ns10:AuditExempt-NoAccountantsReport2023-10-012024-09-3009789457ns10:SmallCompaniesRegimeForDirectorsReport2023-10-012024-09-3009789457ns10:SmallCompaniesRegimeForAccounts2023-10-012024-09-3009789457ns10:FullAccounts2023-10-012024-09-3009789457ns10:OrdinaryShareClass12023-10-012024-09-3009789457ns10:RegisteredOffice2023-10-012024-09-3009789457ns5:CurrentFinancialInstruments2024-09-3009789457ns5:CurrentFinancialInstruments2023-09-3009789457ns5:Non-currentFinancialInstruments2024-09-3009789457ns5:Non-currentFinancialInstruments2023-09-3009789457ns5:ShareCapital2024-09-3009789457ns5:ShareCapital2023-09-3009789457ns5:RetainedEarningsAccumulatedLosses2024-09-3009789457ns5:RetainedEarningsAccumulatedLosses2023-09-3009789457ns5:PlantMachinery2023-10-012024-09-3009789457ns5:FurnitureFittings2023-10-012024-09-3009789457ns5:ComputerEquipment2023-10-012024-09-3009789457ns5:LandBuildingsns5:ShortLeaseholdAssets2023-09-3009789457ns5:PlantMachinery2023-09-3009789457ns5:FurnitureFittings2023-09-3009789457ns5:LandBuildingsns5:ShortLeaseholdAssets2023-10-012024-09-3009789457ns5:LandBuildingsns5:ShortLeaseholdAssets2024-09-3009789457ns5:PlantMachinery2024-09-3009789457ns5:FurnitureFittings2024-09-3009789457ns5:LandBuildingsns5:ShortLeaseholdAssets2023-09-3009789457ns5:PlantMachinery2023-09-3009789457ns5:FurnitureFittings2023-09-3009789457ns5:MotorVehicles2023-09-3009789457ns5:ComputerEquipment2023-09-3009789457ns5:MotorVehicles2023-10-012024-09-3009789457ns5:MotorVehicles2024-09-3009789457ns5:ComputerEquipment2024-09-3009789457ns5:MotorVehicles2023-09-3009789457ns5:ComputerEquipment2023-09-3009789457ns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2023-09-3009789457ns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2023-10-012024-09-3009789457ns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2024-09-3009789457ns5:PlantMachineryns5:LeasedAssetsHeldAsLessee2023-09-3009789457ns5:WithinOneYearns5:CurrentFinancialInstruments2024-09-3009789457ns5:WithinOneYearns5:CurrentFinancialInstruments2023-09-3009789457ns5:Non-currentFinancialInstrumentsns5:MoreThanFiveYears2024-09-3009789457ns5:Non-currentFinancialInstrumentsns5:MoreThanFiveYears2023-09-3009789457ns10:OrdinaryShareClass12024-09-3009789457ns5:RetainedEarningsAccumulatedLosses2023-09-3009789457ns5:RetainedEarningsAccumulatedLosses2023-10-012024-09-30
REGISTERED NUMBER: 09789457 (England and Wales)









Unaudited Financial Statements

for the Year Ended 30 September 2024

for

Evamed UK Ltd

Evamed UK Ltd (Registered number: 09789457)






Contents of the Financial Statements
for the Year Ended 30 September 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Evamed UK Ltd

Company Information
for the Year Ended 30 September 2024







DIRECTORS: Dr I A Banter
Dr M Papadopoulou





REGISTERED OFFICE: Unit 7
Mulberry Place
Pinnell Road
Eltham
London
SE9 6AR





REGISTERED NUMBER: 09789457 (England and Wales)





ACCOUNTANTS: Nichols & Co ( Accountancy ) Limited
Chartered Accountants
Unit 7
Mulberry Place
Pinnell Road
Eltham
London
SE9 6AR

Evamed UK Ltd (Registered number: 09789457)

Balance Sheet
30 September 2024

30.9.24 30.9.23
Notes £ £
FIXED ASSETS
Tangible assets 5 309,346 397,702

CURRENT ASSETS
Debtors 6 136,619 120,397
Cash at bank and in hand 90,601 95,754
227,220 216,151
CREDITORS
Amounts falling due within one year 7 (306,664 ) (329,739 )
NET CURRENT LIABILITIES (79,444 ) (113,588 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

229,902

284,114

CREDITORS
Amounts falling due after more than one
year

8

(164,768

)

(219,297

)
NET ASSETS 65,134 64,817

CAPITAL AND RESERVES
Called up share capital 9 100 100
Retained earnings 10 65,034 64,717
SHAREHOLDERS' FUNDS 65,134 64,817

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 September 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 September 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Evamed UK Ltd (Registered number: 09789457)

Balance Sheet - continued
30 September 2024


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 20 June 2025 and were signed on its behalf by:




Dr I A Banter - Director



Dr M Papadopoulou - Director


Evamed UK Ltd (Registered number: 09789457)

Notes to the Financial Statements
for the Year Ended 30 September 2024

1. STATUTORY INFORMATION

Evamed UK Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. STATEMENT OF COMPLIANCE

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006.

3. ACCOUNTING POLICIES

BASIS OF PREPARING THE FINANCIAL STATEMENTS
The financial statements have been prepared under the historical cost convention.

TURNOVER
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

TANGIBLE FIXED ASSETS
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life or, if held under a finance lease, over the lease term, whichever is the shorter.
Plant and machinery - 25% on cost
Fixtures and fittings - straight line over life of lease
Computer equipment - 25% on cost

Short leasehold - Straight line over 20 years
Plant and machinery - 25% straight line
Fixtures and fittings - 8 years
Computer equipment - 25% straight line

TAXATION
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

DEFERRED TAX
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Evamed UK Ltd (Registered number: 09789457)

Notes to the Financial Statements - continued
for the Year Ended 30 September 2024

3. ACCOUNTING POLICIES - continued

HIRE PURCHASE AND LEASING COMMITMENTS
Assets obtained under hire purchase contracts or finance leases are capitalised in the balance sheet. Those held under hire purchase contracts are depreciated over their estimated useful lives. Those held under finance leases are depreciated over their estimated useful lives or the lease term, whichever is the shorter.

The interest element of these obligations is charged to profit or loss over the relevant period. The capital element of the future payments is treated as a liability.

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

PENSION COSTS AND OTHER POST-RETIREMENT BENEFITS
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

4. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 6 (2023 - 6 ) .

5. TANGIBLE FIXED ASSETS
Fixtures
Short Plant and and
leasehold machinery fittings
£ £ £
COST
At 1 October 2023 17,460 506,311 159,350
Additions - 3,990 -
At 30 September 2024 17,460 510,301 159,350
DEPRECIATION
At 1 October 2023 2,619 297,340 63,438
Charge for year 873 55,960 17,989
At 30 September 2024 3,492 353,300 81,427
NET BOOK VALUE
At 30 September 2024 13,968 157,001 77,923
At 30 September 2023 14,841 208,971 95,912

Evamed UK Ltd (Registered number: 09789457)

Notes to the Financial Statements - continued
for the Year Ended 30 September 2024

5. TANGIBLE FIXED ASSETS - continued

Motor Computer
vehicles equipment Totals
£ £ £
COST
At 1 October 2023 84,762 25,331 793,214
Additions - - 3,990
At 30 September 2024 84,762 25,331 797,204
DEPRECIATION
At 1 October 2023 16,952 15,163 395,512
Charge for year 13,562 3,962 92,346
At 30 September 2024 30,514 19,125 487,858
NET BOOK VALUE
At 30 September 2024 54,248 6,206 309,346
At 30 September 2023 67,810 10,168 397,702

Fixed assets, included in the above, which are held under hire purchase contracts are as follows:
Plant and
machinery
£
COST
At 1 October 2023
and 30 September 2024 216,000
DEPRECIATION
At 1 October 2023 43,200
Charge for year 43,200
At 30 September 2024 86,400
NET BOOK VALUE
At 30 September 2024 129,600
At 30 September 2023 172,800

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.9.24 30.9.23
£ £
Trade debtors 42,814 34,131
Other debtors 8,735 8,735
Prepayments 85,070 77,531
136,619 120,397

Evamed UK Ltd (Registered number: 09789457)

Notes to the Financial Statements - continued
for the Year Ended 30 September 2024

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
30.9.24 30.9.23
£ £
Other loans 21,854 88,144
Hire purchase contracts 37,800 37,800
Trade creditors 726 11,598
Corporation tax 110,130 3,442
Social security and other taxes 21,465 6,234
Pension Control account 634 547
Other creditors 15,695 6,012
VAT 3,888 4,642
Deposits held 69,599 127,636
Net pay control 10,187 -
Bounce Back Loan 8,688 8,687
CJRS Repayment - 19,985
Directors' current accounts 98 512
Accrued expenses 5,900 14,500
306,664 329,739

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
30.9.24 30.9.23
£ £
Other loans - 2-5 years 53,529 65,188
Hire purchase contracts 98,168 132,350
Bounce Back Loan 13,071 21,759
164,768 219,297

9. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 30.9.24 30.9.23
value: £ £
100 Ordinary £1 100 100

10. RESERVES
Retained
earnings
£

At 1 October 2023 64,717
Profit for the year 253,817
Dividends (253,500 )
At 30 September 2024 65,034

11. RELATED PARTY DISCLOSURES

At the Balance Sheet date, the company owed £15,695 (2023: £6,012) to ESAG Events UK Ltd, a company in which Dr IA Banter is a sole director and shareholder.

The company paid dividends totalling £253,500 (2023: £250,000) during the year.

Evamed UK Ltd (Registered number: 09789457)

Notes to the Financial Statements - continued
for the Year Ended 30 September 2024

12. ULTIMATE CONTROLLING PARTY

There is no ultimate controlling party.

The directors control the company by virtue of their interest in the issued share capital of the company.